Topical Therapy Options for PP
Experts discuss the landscape of topical drugs for plaque psoriasis (PP) and key factors in treatment options.
PP Treatment Efficacy
Tj Chao, MPAS, and Lauren Miller, MPAS, highlight treatment efficacy considerations for plaque psoriasis (PP).
Patient Case #3: 48-Year-Old Male With Plaque Psoriasis
Experts in dermatology review a patient case of a 48-year-old man with plaque psoriasis who is having trouble with topical therapy.
Patient Case #2: 60-Year-Old Female With Chronic Intertrigo
Dermatology experts discuss a patient case concerning a 60-year-old woman with chronic intertriginous psoriasis who is taking a biologic drug for inflammatory bowel disease.
Guidelines and Recommendations for Therapies in AD
Experts in dermatology review recommendations for systemic therapies and JAK inhibitors in the management of AD and other factors that guide treatment selection.
Patient Case #2: Adolescent Male With AD
Jonathan I Silverberg, MD, PhD, MPH; Elizabeth Swanson, MD; Brad Glick, DO, MPH, FAOCD; and Andrew Blauvelt, MD, MBA, discuss their initial impressions of an adolescent patient with AD, focusing on systemic therapy.
Drug Class Considerations for Patients With PP
Lauren Miller, MPAS, and Tj Chao, MPAS, discuss how patient goals and education can inform next steps of treatment for plaque psoriasis (PP).
PP Treatment Selection: Best Practices
Experts offer insights on treatment selection and patient education for plaque psoriasis (PP).
Patient Case #1: 29-Year-Old Female With Plaque Psoriasis
Dawn L. Sammons, DO, FAOCD, FAAD, and Benjamin Lockshin, MD, FAAD, review a case of a female patient with a family history of plaque psoriasis.
Mechanism of Action of Tapinarof in Plaque Psoriasis
Experts discuss the unique mechanism of action of tapinarof and its use in the treatment of plaque psoriasis.
Patient Case #1: AD Treatment Options
Elizabeth Swanson, MD; Brad Glick, DO, MPH, FAOCD; and Andrew Blauvelt, MD, MBA, highlight treatment options for a specific patient with AD, focusing on dupilumab.
Treatment of AD in Clinical Practice
Experts in dermatology review clinical trials for AD treatment and how this data translates into their own practices.
Treatment Considerations and Management of Adverse Events when Treating BCC
Experts in dermatology discuss treatment considerations for particular patient populations, highlighting the importance of managing adverse events aggressively.
Efficacy and Safety of Combination Treatments for BCC
Experts in dermatology discuss the efficacy and safety combining hedgehog pathway inhibitors and immunotherapy as treatment for patients with basal cell carcinoma.
Developing a Multidisciplinary Approach when Treating BCC
Todd Schlesinger, MD and Emily Ruiz, MD offer advice on forming multidisciplinary relationships for the wholistic study and treatment of basal cell carcinoma.
Expert Perspectives in Locally Advanced Basal Cell Carcinoma (BCC) Treatment Options
Emily Ruiz, MD and Todd Schlesinger, MD discuss treatment options for locally advanced basal cell carcinoma, such as immunotherapy and surgery.
Caring for Pediatric Patients With PP
Lauren Miller, MPAS, and Tj Chao, MPAS, offer considerations for treating pediatric patients with plaque psoriasis (PP).
Treatment Options for Pregnant People With PP
Experts discuss plaque psoriasis (PP) treatment options for people who are or may become pregnant.
Efficacy of Tapinarof in Plaque Psoriasis
James Q. Del Rosso, DO, and Dawn L. Sammons, DO, FAOCD, FAAD, review the efficacy of a new topical agent in the treatment of plaque psoriasis, tapinarof, highlighting the remittive data.
Treatment Selection in Plaque Psoriasis
Experts in dermatology discuss newer topical treatments, such as tapinarof, in the management of plaque psoriasis.